Glaxo’s Vaccine Likely Not Cause of U.K. Teen’s Death (Update3)

By Kristen Hallam

Sept. 29 (Bloomberg) — GlaxoSmithKline Plc’s Cervarix vaccine for cervical cancer was unlikely to have caused the death of a 14-year-old girl, local U.K. health authorities said.

The girl, Natalie Morton, died yesterday shortly after receiving the vaccine at her school as part of a program to prevent cervical cancer, according to a statement from the National Health Service branch for Coventry, about 100 miles from London. The health service today quarantined the batch of vaccine used in the shot and Glaxo recalled it “as a further precautionary measure,” the company said today in a statement.

Preliminary results of an autopsy performed by an independent forensic pathologist found the teenager had a “serious underlying health condition which was likely to have caused death,” said Caron Grainger, joint director of public health for the NHS Coventry branch and the Coventry City Council, in a statement released on the agency’s Web site.

“We are awaiting further test results which will take some time,” Grainger said in the statement. “However indications are that it was most unlikely that the HPV vaccination was the cause of death.”

Health authorities informed the teenager’s family of the preliminary results of the autopsy, Grainger said in the statement.


Comment from Leslie

Well, the backlash begins…first the fact, then the denial….Come on everyone – we see this all the time with every drug that is out there.  We have all been told that it is all in our head. B.S. Bottom line it is bad for their profits….Deny to protect their image and ytheir bank accounts. Bet GSk has had their marketing departments scurrying on doing damage control on this one…


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.